Review of science and technology innovation policies in major innovative-oriented countries in response to the COVID-19 pandemic

Biosafety and Health - Tập 5 - Trang 8-13 - 2023
Tao Yun1
1China Science and Technology Exchange Center, Beijing, 100045, China

Tài liệu tham khảo

Consortium, 2021, Repurposed antiviral drugs for Covid-19 - Interim WHO solidarity trial results, N. Engl. J. Med., 384, 497, 10.1056/NEJMoa2023184 L. P, Science, technology and innovation: How coordination at home can help the global fight against COVID-19. https://stip.oecd.org/covid/, 2020 (accessed 02 September 2022). Patrucco, 2022, The impact of Covid-19 on innovation policies promoting Open Innovation, R&D Manage., 52, 273, 10.1111/radm.12495 Y, 2020, Research on the combined application of policy tools in the management of major public health crises: a textual analysis based on the Chinese Central Government’s epidemic control policies, J. Public Adm., 17, 1 Gong, 2020, Early research on COVID-19: A bibliometric analysis, Innovation (Camb), 1 Chenghu, 2020, Big data analysis on COVID-19 epidemic and suggestions on regional prevention and control policy, Bull. Chin. Acad. Sci. (Chinese Version), 35, 4 Yun, 2021, Present situation and prospect of International S&T Cooperation between China and countries participating in the Belt and Road Initiative to combat COVID-19, China Biotechnol., 41, 110 Jeong, 2020, Effective control of COVID-19 in South Korea: Cross-sectional study of epidemiological data, J. Med. Internet Res., 22, 10.2196/22103